PS1-37: Comparison of Antipsychotic Polypharmacy Trends Among Schizophrenia Patients Across Multiple Healthcare Systems

Clinical Medicine and Research - United States
doi 10.3121/cmr.2014.1250.ps1-37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshfield Clinic Research Foundation

Related search

Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

BMC Psychiatry
PsychiatryMental Health
2014English

Antipsychotic Polypharmacy - Confusion Reigns

Psychiatrist
PsychiatryMental Health
2010English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Polypharmacy for Schizophrenia

Current Opinion in Psychiatry
PsychiatryMental Health
2013English

Polypharmacy in Schizophrenia

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2020English

Comparison of Patients Undergoing Switching Versus Augmentation of Antipsychotic Medications During Treatment for Schizophrenia

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2012English

Ziprasidone vs Clozapine in Schizophrenia Patients Refractory to Multiple Antipsychotic Treatments: The MOZART Study

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2009English

Antipsychotic Treatment Patterns and Hospitalizations Among Adults With Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy